{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:35:49Z","timestamp":1760204149285},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.expneurol.2006.03.006","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T15:37:09Z","timestamp":1146152229000},"page":"243-244","source":"Crossref","is-referenced-by-count":7,"title":["Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragments"],"prefix":"10.1016","volume":"199","author":[{"given":"David C.","family":"Rubinsztein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Huntington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2006.03.006_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2006.03.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2005.11.008","article-title":"Small N-terminal mutant huntingtin fragments, but not- wild-type, are mainly present in monomeric form: implications for pathogenesis","author":"Cong","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.006_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.molcel.2004.09.016","article-title":"A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington\u2019s disease","volume":"15","author":"Goehler","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2006.03.006_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archneur.62.1.46","article-title":"Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways","volume":"62","author":"Gunawardena","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.006_bib5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.expneurol.2006.03.006_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0361-9230(01)00599-8","article-title":"New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins","volume":"56","author":"Ko","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2006.03.006_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.200412071","article-title":"Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity","volume":"169","author":"Luo","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2006.03.006_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"mTOR inhibition induces autophagy and reduces toxicity of the Huntington\u2019s disease mutation in Drosophila and mouse models","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2006.03.006_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/1568013033483320","article-title":"The molecular pathology of Huntington\u2019s disease","volume":"3","author":"Rubinsztein","year":"2003","journal-title":"Curr. Med. Chem. Immunol. Endocr. Metab. Agents"},{"key":"10.1016\/j.expneurol.2006.03.006_bib10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1471-4159.2005.03620.x","article-title":"Interaction of huntingtin fragments with brain membranes\u2014Clues to early dysfunction in Huntington\u2019s disease","volume":"96","author":"Soupanki","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.03.006_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","article-title":"SUMO modification of Huntingtin and Huntington\u2019s disease pathology","volume":"304","author":"Steffan","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2006.03.006_bib12","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/hmg\/10.17.1829","article-title":"Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington\u2019s disease","volume":"10","author":"Wyttenbach","year":"2001","journal-title":"Hum. Mol. Genet."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T23:53:59Z","timestamp":1547682839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488606002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0014488606002068"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.03.006","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}